Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling hungry on Mounjaro is normal, particularly in the first few weeks of treatment. Mounjaro (tirzepatide) works by activating GIP and GLP-1 receptors to reduce appetite and slow gastric emptying, but at the starter dose of 2.5mg the appetite effect is often modest. Most people notice a clearer reduction in hunger as the dose increases under their prescriber's guidance. Mounjaro is a prescription-only medicine, and a clinician decides the pace and direction of your treatment plan.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common reason people find themselves still hungry on Mounjaro is straightforward: they're early in treatment, often still on the 2.5mg pen. That first pen's purpose is to settle your digestive system into the medicine. Reduced appetite isn't its primary job, and expecting significant hunger suppression at this stage means expecting something the dose wasn't designed to deliver.
As your prescriber steps you up through 5mg, 7.5mg and beyond, the appetite effect typically becomes more pronounced. This is well-reflected in the SURMOUNT-1 trial, published in the New England Journal of Medicine, where the greatest average weight reductions were seen at the higher doses over 72 weeks. The clinical programme involved thousands of adults, and individual responses varied, which is why titration is a gradual, supervised process rather than a race to the highest dose.
If you've been at the same dose for four weeks or more and hunger hasn't shifted at all, that's a reasonable and important thing to discuss with whoever prescribed your treatment. Don't adjust your dose yourself or change your injection timing without that conversation. The decision about when to move up belongs with your prescriber, and it's based on tolerability as well as efficacy.
You can read more about what happens in those early days when hunger lingers if you've only just started, and if the experience of being on Mounjaro but still feeling hungry is something you're living with right now, that page explores the reasons in more detail.
Mounjaro slows gastric emptying, meaning food stays in your stomach longer, which is part of how it reduces appetite. But this mechanism works best when the food you're eating actually triggers that fullness signal. Ultra-processed foods, particularly those engineered to be palatable without being filling, can sidestep it. You eat, the stomach registers something, but the satiety cue never quite arrives. That's not a sign the medicine isn't working; it's a sign of what you're eating working against it.
Protein is the most satiating macronutrient, and people on tirzepatide who prioritise it at most meals tend to report less background hunger. Fibre-rich vegetables and wholegrains add bulk without excessive calories and slow glucose absorption in a way that complements the GLP-1 mechanism. Hydration matters too: thirst is frequently mistaken for hunger, and mild dehydration is common in the early GI-adjustment period when nausea or reduced appetite cuts your fluid intake. Keep water accessible throughout the day, whether that's a bottle in your gym bag or a glass beside wherever you most often sit.
For a more detailed guide to which foods tend to work well alongside treatment, our page on what to eat on Mounjaro covers this in full.
If the opposite is your problem and eating feels difficult even when you're trying, that's a different picture worth addressing: struggling to eat on Mounjaro is also something we've covered.
Being on Mounjaro and still hungry occasionally is not always something that needs fixing. Hunger is a physiological signal, and some residual hunger between meals is normal and healthy. The question your prescriber is really interested in is whether hunger is driving you to eat in ways that are preventing progress, or whether it's simply background noise that doesn't translate into overeating.
There are also patterns that can trigger hunger that have nothing to do with whether Mounjaro is working: poor sleep elevates ghrelin (the hunger hormone), high stress raises cortisol, and irregular meal timing can produce genuine appetite spikes. None of these are failures of the medicine. They are the biological context in which the medicine is operating, and they're worth mentioning to your clinical team because they can be addressed practically.
The NHS patient information for tirzepatide gives a clear overview of how the medicine works and what to expect, which is a useful reference alongside your Patient Information Leaflet. And if you're wondering whether your experience differs from what others describe, the question of why some people are still hungry on Mounjaro explores the individual variation in more depth.
Mounjaro is available privately without a waiting list through regulated services when you're clinically suitable. For people thinking about the cost of private treatment, it's worth understanding what a legitimate prescription service includes before making any decisions. If you'd like to explore whether treatment is right for you, check your eligibility with our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.